Journal
NATURE REVIEWS RHEUMATOLOGY
Volume 8, Issue 12, Pages 701-709Publisher
NATURE PORTFOLIO
DOI: 10.1038/nrrheum.2012.142
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [30971632, 81025016]
- Program of the Shanghai Commission of Science and Technology [10JC1409300]
Ask authors/readers for more resources
Dysregulation of gene expression can cause complex disease phenotypes. MicroRNAs (miRNAs) are well known to fine-tune cellular gene expression to control immune cell development and regulate adaptive and innate immune responses. Discoveries over the past decade have indicated that aberrant expression of miRNAs is associated with the pathogenesis of multiple immunological diseases, including systemic lupus erythematosus (SLE). Indeed, profiling miRNA expression in blood cells, body fluid and target tissues taken from patients with SLE has revealed unique miRNA signatures when compared with healthy individuals or those with other diseases. Moreover, dysregulation of these miRNAs has also been found to be associated with disease activity and major organ involvement. In our opinion, therefore, miRNAs have the potential to act as biomarkers for the diagnosis and assessment of patients with SLE. This Review provides an overview of the novel cellular and molecular mechanisms that seem to underlie the roles of miRNAs in SLE disease processes, as well as the future therapeutic potential of targeting miRNAs in the management of patients with SLE. Shen, N. et al. Nat. Rev. Rheumatol. 8, 701-709 (2012); published online 16 October 2012; doi:10.1038/nrrheum.2012.142
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available